Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ENGN compared with LXRX: revenue, margins and what each company keeps, and the suppliers and customers both name
ENGN
enGene Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LXRX
Lexicon Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ENGN
enGene Therapeutics Inc.
vs
LXRX
Lexicon Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ENGN, solid
LXRX, dashed
ENGN
enGene Therapeutics Inc.
Change
1.75
▲
+4.17%
· post 1.75
Mkt cap
$117.3M
Revenue
—
Revenue
—
LXRX
Lexicon Pharmaceuticals, Inc.
Change
1.79
▲
+11.04%
· post 1.79
Closed
Nov 6 '26
Mkt cap
$792.5M
Revenue
$11M
Q3 FY26
Revenue
$144M
FY25
vs
Compare
Closed
Nov 6 '26
ENGN
enGene Therapeutics Inc.
vs
LXRX
Lexicon Pharmaceuticals, Inc.
1.75
▲
+4.17%
post 1.75
Price
1.79
▲
+11.04%
post 1.79
$117.3M
Mkt cap
$792.5M
—
Revenue
$11M
Q3 FY26
—
Revenue
$144M
FY25
Change
Change
ENGN
1.75
▲
+4.17%
vs
LXRX
1.79
▲
+11.04%
Closed
Nov 6 '26